CD40LG and COVID-19: Our study demonstrated essentially no anti-SARS-CoV-2 antibodies in pre-pandemic human plasmas and much higher levels of anti-SARS-CoV-2 IgG and IgM in the COVID-19 patients than the commercial assay kits.